Literature DB >> 25266556

Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study.

Enayat Attwa1, Mohamed Khater, Magda Assaf, Manal Abdel Haleem.   

Abstract

BACKGROUND: Melasma is a common pigmentary disorder that remains resistant to available therapies.
OBJECTIVES: The aim of the present study was to evaluate the efficacy of erbium:YAG lasers in the treatment of refractory melasma and investigate the histopathological and ultrastructural changes between melasma skin and adjacent control skin before and after surgery.
METHODS: Fifteen Egyptian female patients with melasma unresponsive to previous therapy of bleaching creams and chemical peels were included in this study. Full-face skin resurfacing using an erbium:YAG laser was performed. Clinical parameters included physician and patient assessment, and melasma area and severity index score were done. Adverse effects after laser resurfacing were recorded. Biopsies of lesions and adjacent healthy skin were stained using hematoxylin-eosin, immunohistochemically marked for Melan-A, and evaluated by electron microscopy.
RESULTS: The amount of melanin, staining intensity, and number of epidermal melanocytes are increased in melasma lesions as compared to normal skin. Electron microscopic analysis revealed an increased number of mature melanosomes in keratinocytes and melanocytes, with more marked cytoplasmic organelles in melasma skin than in biopsy specimens from normal skin, suggesting increased cell activity. After surgery, the number of melanocytes and concentration of melanin decreased in melasma skin, and the mean melasma area and severity index score decreased dramatically.
CONCLUSIONS: Erbium:YAG laser resurfacing effectively improves melasma; however, the almost universal appearance of transient postinflammatory hyperpigmentation necessitates prompt and persistent intervention.
© 2014 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25266556     DOI: 10.1111/ijd.12477

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  7 in total

1.  A split-face comparison of fractional erbium: YAG laser plus Kligman's formula vs. Kligman's formula monotherapy for facial melasma.

Authors:  Maryam Nasimi; Maryam Ghiasi; Vahideh Lajevardi; Fatemeh Nasiri; Safoura Shakoei
Journal:  Arch Dermatol Res       Date:  2021-10-27       Impact factor: 3.033

2.  The Split-Face Comparison of the Combined Er-YAG Laser and Hydroquinone 4% With Hydroquinone 4% Alone in the Treatment of Melasma in Iranian Patients: A Prospective, Interventional Case Study.

Authors:  Nastaran Namazi; Aida Hesami; Yasaman Ketabi
Journal:  J Lasers Med Sci       Date:  2020-01-18

3.  Lasers in Melasma: A Review with Consensus Recommendations by Indian Pigmentary Expert Group.

Authors:  Rashmi Sarkar; Sanjeev Aurangabadkar; T Salim; Anupam Das; Swapnil Shah; Imran Majid; Mohan Singh; G Ravichandran; Kiran Godse; Shehnaz Arsiwala; Latika Arya; Narendra Gokhale; Nilendu Sarma; R G Torsekar; Sidharth Sonthalia; V K Somani
Journal:  Indian J Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.494

4.  Evidence-based Review, Grade of Recommendation, and Suggested Treatment Recommendations for Melasma.

Authors:  Nilendu Sarma; Sayantani Chakraborty; Shital A Poojary; Sanjay Rathi; Sendhil Kumaran; Balakrishnan Nirmal; Joan Felicita; Rashmi Sarkar; Prashansa Jaiswal; Paschal D'Souza; Nagaraju Donthula; Sumit Sethi; Pallavi Ailawadi; Bebisha Joseph
Journal:  Indian Dermatol Online J       Date:  2017 Nov-Dec

Review 5.  Updates in the understanding and treatments of skin & hair disorders in women of color.

Authors:  Christina N Lawson; Jasmine Hollinger; Sumit Sethi; Ife Rodney; Rashmi Sarkar; Ncoza Dlova; Valerie D Callender
Journal:  Int J Womens Dermatol       Date:  2015-05-27

Review 6.  Updates in the understanding and treatments of skin & hair disorders in women of color.

Authors:  Christina N Lawson; Jasmine Hollinger; Sumit Sethi; Ife Rodney; Rashmi Sarkar; Ncoza Dlova; Valerie D Callender
Journal:  Int J Womens Dermatol       Date:  2017-02-16

7.  Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma.

Authors:  Ashraf M Badawi; Mai Abdelraouf Osman
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.